SPRO vs. TQQQ

In the year-to-date period, SPRO achieves a 142.72% return, which is significantly higher than TQQQ's -11.28% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Spero Therapeutics, Inc. (SPRO) and ProShares UltraPro QQQ (TQQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current SPRO Sharpe Ratio is 0.30, which is higher than the TQQQ Sharpe Ratio of 0.18. The chart below compares the historical Sharpe Ratios of SPRO and TQQQ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

SPRO has not paid dividends to shareholders, while TQQQ's dividend yield for the trailing twelve months is around 1.41%.

The maximum SPRO drawdown since its inception was -97.46%, which is greater than TQQQ's maximum drawdown of -81.66%. Use the drawdown chart below to compare losses from any high point for SPRO and TQQQ.

Spero Therapeutics, Inc. (SPRO) has a higher volatility of 126.14% compared to ProShares UltraPro QQQ (TQQQ) at 16.41%. This indicates that SPRO's price experiences larger fluctuations and is considered to be riskier than TQQQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.